Pharmaceutical
-
Vanderbilt licenses compound to Nashville’s Appello to advance Parkinson’s therapies
Appello was established with major investment from New York-based Deerfield Management, which specializes in accelerating drug development projects at universities and other nonprofits. Read MoreJun 29, 2018
-
Mad as a Hatter: Global efforts to reduce mercury emissions
Last month representatives of more than 140 countries agreed to the terms of a treaty called the Minamata Convention that would ban many uses of mercury by 2020. But the efforts do not go far enough, says Vanderbilt pharmacologist Michael Aschner. Read MoreFeb 18, 2013
-
Novel method of peptide synthesis promises to lower cost, increase availability of new drugs based on natural compounds
Graduate student Dawn Makley holds a model of a peptide molecule created using a new synthesis method developed in the laboratory of Prof. Jeff Johnston. Photo credit: Steve Green A team of Vanderbilt chemists has developed a novel method for chemically synthesizing peptides that promises to lower… Read MoreJun 23, 2010